DNA Repair

Introduction

Introduction to DNA Repair

DNA repair is a critical cellular process that maintains genomic integrity by correcting damage caused by endogenous and exogenous agents. Errors in DNA replication, exposure to ultraviolet (UV) radiation, chemical mutagens, and oxidative stress can introduce lesions such as base modifications, single-strand breaks (SSBs), and double-strand breaks (DSBs). Failure to repair these lesions can lead to mutations, genomic instability, and diseases such as cancer. DNA repair mechanisms are highly conserved across species and are essential for cell survival and proper function.

Importance of DNA Repair in Cellular Homeostasis

The integrity of the genome is constantly threatened by both metabolic byproducts and environmental factors. For example, reactive oxygen species (ROS) generated during cellular respiration can oxidize DNA bases, while UV light induces pyrimidine dimers. DNA repair pathways not only correct these lesions but also regulate cell cycle progression, apoptosis, and immune responses. Defects in DNA repair are associated with hereditary cancer syndromes, such as Lynch syndrome and xeroderma pigmentosum, underscoring the clinical significance of these processes.

Study

Direct Reversal Repair

Direct reversal repair is the simplest DNA repair mechanism, as it corrects damage without excising nucleotides. One well-characterized example is the repair of O6-methylguanine, a mutagenic lesion caused by alkylating agents. The enzyme O6-methylguanine-DNA methyltransferase (MGMT) directly removes the methyl group from the guanine base, restoring its normal structure. This process is stoichiometric, as MGMT is irreversibly inactivated after transferring the methyl group to one of its cysteine residues. While efficient, this pathway is limited to specific types of damage and does not involve complex protein assemblies.

Base Excision Repair (BER)

Base excision repair (BER) is responsible for correcting small, non-helix-distorting base lesions, such as those caused by oxidation, deamination, or alkylation. The process begins with a DNA glycosylase recognizing and excising the damaged base, creating an apurinic/apyrimidinic (AP) site. AP endonuclease then cleaves the phosphodiester backbone, and DNA polymerase β fills the gap with the correct nucleotide. Finally, DNA ligase seals the nick. BER is highly specific and involves a coordinated interplay of enzymes, including glycosylases like uracil-DNA glycosylase (UDG) and 8-oxoguanine glycosylase (OGG1).

Nucleotide Excision Repair (NER)

Nucleotide excision repair (NER) targets bulky, helix-distorting lesions, such as pyrimidine dimers induced by UV radiation. NER operates through two subpathways: global genome NER (GG-NER), which surveys the entire genome, and transcription-coupled NER (TC-NER), which repairs damage in actively transcribed genes. The process involves damage recognition, dual incision of the damaged strand by endonucleases (e.g., XPF-ERCC1 and XPG), excision of a 24–32 nucleotide oligomer, and gap filling by DNA polymerase δ or ε. Defects in NER proteins, such as those encoded by the XP genes, result in xeroderma pigmentosum, a condition characterized by extreme UV sensitivity and skin cancer predisposition.

Mismatch Repair (MMR)

Mismatch repair (MMR) corrects errors that escape proofreading during DNA replication, such as base-base mismatches and insertion-deletion loops. In prokaryotes, the MutS protein recognizes the mismatch, while MutL and MutH coordinate the excision of the newly synthesized strand. In eukaryotes, homologs of MutS (MSH2, MSH6) and MutL (MLH1, PMS2) perform analogous functions. The excised strand is degraded, and DNA polymerase δ resynthesizes the correct sequence. Deficiencies in MMR, often due to mutations in MLH1 or MSH2, lead to microsatellite instability and are associated with Lynch syndrome, a hereditary cancer predisposition.

Double-Strand Break Repair

Double-strand breaks (DSBs) are among the most cytotoxic DNA lesions, as they can lead to chromosomal rearrangements if improperly repaired. Cells employ two primary mechanisms to repair DSBs: non-homologous end joining (NHEJ) and homologous recombination (HR). NHEJ directly ligates broken DNA ends, often with minimal processing, which can result in small insertions or deletions. HR, on the other hand, uses a homologous template (e.g., the sister chromatid) to ensure accurate repair. Key proteins in HR include the MRN complex (MRE11-RAD50-NBS1), RAD51, and BRCA1/2. Defects in HR, such as mutations in BRCA1 or BRCA2, predispose individuals to breast and ovarian cancers.

Summary

Key Takeaways

DNA repair mechanisms are essential for maintaining genomic stability and preventing mutations that can lead to cancer and other diseases. Major pathways include direct reversal repair, base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), and double-strand break repair (NHEJ and HR). Each pathway targets specific types of DNA damage and involves a coordinated sequence of enzymatic steps. Understanding these processes is critical for appreciating the molecular basis of hereditary cancer syndromes and developing targeted therapies.

Clinical Correlate

Defects in DNA repair pathways are linked to several hereditary cancer syndromes. For example, mutations in NER genes cause xeroderma pigmentosum, characterized by extreme UV sensitivity and skin cancer risk. Lynch syndrome, associated with MMR deficiencies, increases the risk of colorectal and endometrial cancers. BRCA1/2 mutations impair homologous recombination, predisposing individuals to breast and ovarian cancers. Therapeutically, PARP inhibitors exploit synthetic lethality in HR-deficient tumors, offering a targeted approach for patients with BRCA mutations.

Emerging Concepts

Recent advances in DNA repair research have highlighted the interplay between repair pathways and other cellular processes, such as transcription, replication, and chromatin remodeling. For instance, the DNA damage response (DDR) integrates signals from multiple repair pathways to regulate cell cycle checkpoints and apoptosis. Additionally, the role of RNA in DNA repair is an emerging area of study, with evidence suggesting that RNA molecules may participate in damage recognition and repair. These insights are paving the way for novel therapeutic strategies targeting DNA repair in cancer and other diseases.